1. World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard. Vol. 2020 (World Health organization, 2020).
2. Carfì, A., Bernabei, R. & Landi, F. Persistent Symptoms in Patients After Acute COVID-19. Jama 324, 603-605 (2020).
3. Huang, C., et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet (London, England) 397, 220-232 (2021).
4. Nehme, M., et al. COVID-19 Symptoms: Longitudinal Evolution and Persistence in Outpatient Settings. Annals of internal medicine (2020).
5. Ayoubkhani, D., et al. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ (Clinical research ed.) 372, n693 (2021).
6. Nehme, M., Braillard, O., Chappuis, F., Courvoisier, D.S. & Guessous, I. Prevalence of Symptoms More Than Seven Months After Diagnosis of Symptomatic COVID-19 in an Outpatient Setting. Annals of internal medicine (2021).
7. Taquet, M., Geddes, J.R., Husain, M., Luciano, S. & Harrison, P.J. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. The lancet. Psychiatry (2021).
8. Seeßle, J., et al. Persistent symptoms in adult patients one year after COVID-19: a prospective cohort study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021).
9. Davis, H., et al. Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact. medRxiv (2020).
10. Tran, V.T. & Ravaud, P. COllaborative open platform E-cohorts for research acceleration in trials and epidemiology. Journal of clinical epidemiology 124, 139-148 (2020).
11. Office for National Statistics. Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 2 September 2021. (London, UK, 2021).
12. Institut National de la Statistique et des etudes économiques. La macro SAS CALMAR. in Modèles, méthodes et outils statistiques, Vol. 2019 (Institut National de la Statistique et des etudes économiques, 2018).
13. Tran, V.T., et al. Development and validation of the long covid symptom and impact tools, a set of patient-reported instruments constructed from patients' lived experience. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021).
14. NICE. COVID-19 rapid guideline: managing the long-term effects of COVID-19. (NICE, 2020).
15. Miyazato, Y., et al. Prolonged and Late-Onset Symptoms of Coronavirus Disease 2019. Open forum infectious diseases 7, ofaa507 (2020).
16. Nalbandian, A., et al. Post-acute COVID-19 syndrome. Nature medicine 27, 601-615 (2021).
17. Takahashi, T., et al. Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature 588, 315-320 (2020).
18. Christiansen, D.M. & Berke, E.T. Gender- and Sex-Based Contributors to Sex Differences in PTSD. Current psychiatry reports 22, 19 (2020).
19. Bury, M. Chronic illness as biographical disruption. Sociology of health & illness 4, 167-182 (1982).
20. van Gelder, M.M., Bretveld, R.W. & Roeleveld, N. Web-based questionnaires: the future in epidemiology? American journal of epidemiology 172, 1292-1298 (2010).
21. Huang, L., et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet (London, England) 398, 747-758 (2021).
22. Soriano, J., et al. A clinical case definition of post COVID-19 condition by a Delphi consensus. (World Health Organization, 2021).